Literature DB >> 4075437

Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.

A M Fichtinger-Schepman, R A Baan, A Luiten-Schuite, M van Dijk, P H Lohman.   

Abstract

Antibodies elicited against the haptens cis-Pt(NH3)2dGuodGMP and its ribo-analog, both covalently coupled to bovine serum albumin, recognize adducts of cis-diamminedichloroplatinum(II) (cis-DDP) in DNA. Antibody-binding to cis-DDP-DNA strongly depends on the accessibility of the adducts to the antibodies. In double-stranded cis-DDP-DNA with low Pt: nucleotide ratios (rb's), this accessibility is enhanced by unwinding of the cis-DDP-DNA, e.g. by heat-denaturation. An unwinding effect is also induced by the cis-DDP treatment itself. A260nm readings of cis-DDP-DNA samples indicate an increased denaturation of the DNA at increasing Pt-contents. The data obtained after heat-denaturation of the same samples show a growing capability to renaturation when the rb-values increase from 0 to 0.04; at 0.04 less than rb less than 0.18 the renaturation effect gradually disappears. In the competitive enzyme-linked immunosorbent assay (ELISA), the cis-DDP-adducts in heat-denatured DNA are detected in the pmol range; in DNA-digests, however, they are recognized in fmol amounts. For the individual Pt-containing (oligo)nucleotides the amounts causing 50% inhibition in the ELISA were established for the two anti-sera; they were 13.3 +/- 3.8 (fmol +/- S.D.) and 5.4 +/- 1.8 for cis-Pt(NH3)2d(GMP)2; 15.5 +/- 5.4 and 4.0 +/- 1.5 for cis-Pt(NH3)2d(pGpG); (2.6 +/- 1.1) X 10(3) and (2.0 +/- 1.0) X 10(3) for cis-Pt(NH3)2d(pApG); (5.6 +/- 1.9) X 10(3) and (2.9 +/- 0.4) X 10(3) for Pt(NH3)3dGMP. Pt-adducts in a trans-DDP-DNA digest are recognized in pmol amounts and dGMP in nmol quantitatives. Finally, the usefulness of these antibodies for the detection and quantitation of individual cis-DDP-adducts in cis-DDP-DNA digests was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075437     DOI: 10.1016/s0009-2797(85)80135-6

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  12 in total

Review 1.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

2.  Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells.

Authors:  R C Rietbroek; P J van de Vaart; J Haveman; F A Blommaert; A Geerdink; P J Bakker; C H Veenhof
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Detection of platinum-DNA adducts by 32P-postlabelling.

Authors:  F A Blommaert; C P Saris
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

4.  cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.

Authors:  Katherine S Lovejoy; Ryan C Todd; Shuzhong Zhang; Michael S McCormick; J Alejandro D'Aquino; Joyce T Reardon; Aziz Sancar; Kathleen M Giacomini; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

5.  Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.

Authors:  P M Terheggen; B G Floot; E L Lempers; O van Tellingen; A C Begg; L den Engelse
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 6.  Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.

Authors:  George D Cimino; Chong-xian Pan; Paul T Henderson
Journal:  Bioanalysis       Date:  2013-02       Impact factor: 2.681

7.  Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.

Authors:  B Peng; M J Tilby; M W English; L Price; A D Pearson; A V Boddy; D R Newell
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.

Authors:  C Meijer; E G de Vries; W A Dam; M H Wilkinson; H Hollema; H J Hoekstra; N H Mulder
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.

Authors:  C Meijer; N H Mulder; G A Hospers; D R Uges; E G de Vries
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

10.  Cis dichlorodiammine platinum induced DNA interstrand cross-links in primary cultures of human ovarian cancer.

Authors:  G Balconi; Y Pang; M Broggini; F Morali; M Marzola; E Erba; M Ponti; L Spinelli; C Mangioni; L Redaelli
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.